Page 81 - Sohini Das

Hetero recalls a batch of its remdesivir brand Covifor after side effects

Some patients in Raigad district of Maharashtra developed side effects like fever and chills

Have got full advance for 110 mn doses, says Serum CEO Poonawalla

Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine

Gujarat gets the lion's share of Covid vaccines on Day 1 of the new phase

Health ministry data shows a huge disparity in the doses that were given in just eleven states which could launch the drive on May 1 due to paucity of supply

Phase 3 of Covid vaccination in Maharashtra gets off to a slow start

Mumbai started vaccinations for everyone aged above 18 from around 2 pm at only five BMC-run centres, which had a target of 200 vaccinations per centre

Vax 3.0: Hospitals, states ready for a slow start for those above 18 years

Maharashtra, Gujarat and UP to begin vaccination today

Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step

Bharat Biotech follows SII, reduces Covaxin price to Rs 400 for states

Earlier, the Bharat Biotech vaccine was priced at Rs 600 a dose

Serum cuts Covishield price by 25% for states, no change for pvt hospitals

Bharat Biotech is yet to announce any change in prices of Covaxin

Spiralling demand, leakages and a flourishing black market for remdesivir

Artificial shortages and brazen hawking of the drug on the streets at 15x the normal price rule the day as the official machinery tries desparately to stamp out the parallel market

Roche seeking fast approval of antibody cocktail in India to treat Covid

Co says demand for tocilizumab may exceed supplies it can provide

Return unused Covid-19 vaccine stock, govt tells private hospitals

Leading facilities in Mumbai, Delhi, Bengaluru have got communication in this regard

After states' objection, Centre asks vaccine manufacturers to lower prices

SII and Bharat Biotech had announced prices for state government procurement and for institutional sale to private hospitals

Centre clears the air on procurement of Covishield vaccine for states

Vaccination for those aged above 18 years could see a slow start in May

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

India could get its fourth vaccine by August, says NITI Aayog's V K Paul

Hyderabad-based Biological E's candidate has completed its phase one and two trials and is about to enter stage three

Serum prices Covishield at Rs 400 for Centre, Rs 600 for private hospitals

These are the prices for institutional sales, and not the maximum retail price, which will be announced later.

Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May

The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

The B.1.617 or 'double mutant' Indian variant carries two mutations, including the L452R and E484Q

Covaxin shows 100% efficacy against 'severe Covid-19', 78% overall

The Bharat Biotech candidate has also shown 70 per cent efficacy against asymptomatic infections, suggesting that it prevents transmission

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales